Your browser is no longer supported. Please, upgrade your browser.
Settings
QGEN QIAGEN N.V. daily Stock Chart
QGEN [NYSE]
QIAGEN N.V.
Index- P/E- EPS (ttm)-0.13 Insider Own3.60% Shs Outstand230.18M Perf Week-0.83%
Market Cap9.64B Forward P/E28.20 EPS next Y1.49 Insider Trans0.00% Shs Float224.17M Perf Month36.30%
Income-25.40M PEG- EPS next Q0.44 Inst Own72.00% Short Float3.00% Perf Quarter22.23%
Sales1.52B P/S6.36 EPS this Y4.50% Inst Trans1.35% Short Ratio2.86 Perf Half Y8.66%
Book/sh10.89 P/B3.85 EPS next Y6.07% ROA-0.50% Target Price34.73 Perf Year15.43%
Cash/sh3.47 P/C12.07 EPS next 5Y8.08% ROE-1.00% 52W Range25.04 - 43.16 Perf YTD21.63%
Dividend- P/FCF46.35 EPS past 5Y22.50% ROI4.80% 52W High-3.20% Beta1.01
Dividend %- Quick Ratio2.20 Sales past 5Y2.90% Gross Margin65.40% 52W Low66.85% ATR0.88
Employees5200 Current Ratio2.40 Sales Q/Q1.30% Oper. Margin-0.90% RSI (14)79.42 Volatility1.46% 2.45%
OptionableYes Debt/Eq0.71 EPS Q/Q-376.40% Profit Margin-1.70% Rel Volume1.20 Prev Close41.90
ShortableYes LT Debt/Eq0.68 EarningsOct 30 AMC Payout- Avg Volume2.35M Price41.78
Recom2.70 SMA207.90% SMA5025.74% SMA20013.25% Volume2,807,589 Change-0.29%
Nov-15-19Initiated Stifel Hold
Nov-14-19Upgrade Kepler Reduce → Hold
Nov-14-19Upgrade JP Morgan Underweight → Overweight
Nov-14-19Upgrade Evercore ISI In-line → Outperform
Oct-17-19Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19Downgrade Kepler Hold → Reduce
Oct-08-19Downgrade JP Morgan Neutral → Underweight
Oct-08-19Downgrade Deutsche Bank Buy → Hold
Oct-08-19Downgrade Barclays Overweight → Equal Weight
Jul-16-19Downgrade Evercore ISI Outperform → In-line
Jul-12-19Upgrade Exane BNP Paribas Neutral → Outperform
May-30-19Initiated Wolfe Research Peer Perform
Mar-15-19Initiated UBS Neutral
Jan-29-18Initiated Goldman Buy $39
Nov-03-16Upgrade BofA/Merrill Underperform → Neutral
Aug-01-16Upgrade HSBC Securities Hold → Buy
Aug-01-16Reiterated Mizuho Neutral $22 → $25
Feb-03-16Reiterated Barclays Overweight $28 → $27
Nov-12-15Initiated Stifel Hold
Sep-15-15Initiated Morgan Stanley Overweight $33
Nov-28-19 08:15AM  QIAGEN and DiaSorin Get FDA Approval for LIAISON QFT-Plus Zacks
Nov-27-19 07:26AM  The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen Benzinga
02:00AM  QIAGEN and DiaSorin Receive FDA Approval for The LIAISON QuantiFERON-TB Gold Plus Test on LIAISON Platforms and Begin Commercial Launch TEST Business Wire Releases
Nov-25-19 05:02PM  ROSEN, A GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against QIAGEN N.V. QGEN GlobeNewswire
Nov-21-19 08:42AM  QIAGEN Expands Existing Deal With LabCorp for Better Treatment Zacks
Nov-20-19 04:07PM  QIAGEN and LabCorp deepen relationship with widespread use of bioinformatics solutions Business Wire
09:30AM  OSMT or QGEN: Which Is the Better Value Stock Right Now? Zacks
Nov-19-19 07:56AM  The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout Benzinga
Nov-18-19 10:24AM  QIAGEN Rides on Solid QuantiFERON-TB Sales Amid Several Woes Zacks
06:52AM  Dutch Diagnostics Group Qiagen Is Looking Like a Hot Acquisition And Shares Are Soaring Barrons.com
05:56AM  Qiagen shares surge as diagnostics group says open to takeover talks Reuters
05:09AM  European stocks tread water after six winning weeks MarketWatch
03:03AM  European shares extend winning streak; Qiagen jumps as company explores sale Reuters
Nov-17-19 08:35PM  Qiagen/DNA: cell high Financial Times
Nov-15-19 05:12PM  Medtech Stock With 28% Gain This Week Confirms It's Fielding Buyout Bids Investor's Business Daily +8.80%
04:19PM  QIAGEN Receives Several Conditional, Non-binding Indications of Interest, and Decides to Enter Into Discussions to Explore Potential Strategic Alternatives Business Wire
03:58PM  UPDATE 1-Qiagen exploring sale after indications of interest Reuters
03:45PM  QIAGEN receives several conditional, non-binding indications of interest, and decides to enter into discussions to explore potential strategic alterna-tives ACCESSWIRE
03:22PM  QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strategic Alternatives Business Wire
Nov-14-19 04:23PM  This Medtech Stock Jumped Bullishly On A Rumored $8 Billion Takeover Investor's Business Daily +5.16%
02:14PM  JPMorgan Upgrades Qiagen After Product Surveys, Valuation Analysis Benzinga
09:15AM  Qiagen's stock extends surge after J.P. Morgan swings to bullish from bearish MarketWatch
09:00AM  QIAGEN (QGEN) Catches Eye: Stock Jumps 9.9% Zacks
07:14AM  Thermo Fisher Considers Buying $8 Billion Diagnostics Firm Qiagen Bloomberg
05:22AM  European stocks edge lower on China trade concerns and worst of all worlds German economic data MarketWatch
04:35AM  [video]Qiagen Jumps on Report Thermo Fisher Is Considering a Bid TheStreet.com
Nov-13-19 08:03PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Qiagen (QGEN) Investors with Significant Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud GlobeNewswire +9.89%
05:32PM  Thermo Fisher approaches genetic testing specialist Qiagen for deal - Bbg Reuters
Nov-12-19 04:56PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of QIAGEN N.V. GlobeNewswire
Nov-10-19 11:00AM  ROSEN, A LEADING GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against QIAGEN N.V. QGEN Business Wire
Nov-06-19 10:20AM  EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of QIAGEN N.V. GlobeNewswire
01:30AM  QIAGEN Launches Novel NGS Workflow for Simultaneous DNA and RNA Analysis for Use in Cancer Profiling at 2019 AMP Annual Meeting Business Wire
Nov-05-19 04:05PM  QIAGEN Expands Portfolio of Immuno-Oncology Assets for Future Companion Diagnostics and Biomarkers Business Wire
Nov-04-19 05:39PM  Edited Transcript of QGEN earnings conference call or presentation 31-Oct-19 1:00pm GMT Thomson Reuters StreetEvents
Nov-01-19 08:10PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Qiagen (QGEN) Investors with Significant Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud GlobeNewswire
Oct-31-19 08:09AM  QIAGEN (QGEN) Beats Q3 Earnings Estimates, Cuts Revenue View Zacks
Oct-30-19 08:05PM  Qiagen (QGEN) Tops Q3 Earnings Estimates Zacks
04:05PM  QIAGEN Reports Full Results for Third Quarter and First Nine Months of 2019 Business Wire
Oct-29-19 05:05PM  QIAGENs QuantiFERON®-TB Gold Plus Test Added to the Global Drug Facility Catalog for Public Health Efforts Business Wire
Oct-24-19 01:45PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
07:00AM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMINDS QIAGEN (QGEN) SHAREHOLDERS OF ONGOING INVESTIGATION: Investors Who Suffered Significant Losses Encouraged to Contact the Firm Now ACCESSWIRE
Oct-23-19 11:45AM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:34AM  Qiagen (QGEN) Q3 Earnings Preview: What's in the Cards? Zacks
Oct-22-19 08:35PM  Bragar Eagel & Squire, P.C. Is Investigating HEXO, Pareteum, Qiagen, and Zendesk on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
01:00PM  SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:25PM  Can We See Significant Institutional Ownership On The QIAGEN N.V. (NYSE:QGEN) Share Register? Simply Wall St.
06:00AM  QIAGEN (QGEN) Alert: Johnson Fistel Launches Investigation into QIAGEN N.V.; Investors Encouraged to Contact Firm PR Newswire
Oct-21-19 09:48AM  QIAGEN to Report Results for Q3 and First Nine Months Of 2019 Business Wire
Oct-20-19 06:45PM  Were Hedge Funds Right About Piling Into Qiagen NV (QGEN)? Insider Monkey
Oct-17-19 03:00PM  SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-15-19 10:28PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
08:05PM  QGEN SHAREHOLDER REMINDER: Hagens Berman Reminds Investors in Qiagen (QGEN) of Firms Ongoing Investigation Involving Possible Securities Law Violations GlobeNewswire
08:31AM  QIAGEN (QGEN) Launches QIAseq FastSelect Technology Kits Zacks
Oct-14-19 07:00PM  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Continues to Investigate Securities Claims Against QIAGEN N.V.; Encourages Investors with Losses in Excess of $100K to Contact the Firm QGEN GlobeNewswire
04:05PM  QIAGEN Launches New QIAseq FastSelect Solutions to Accelerate RNA-seq Business Wire
Oct-12-19 01:12PM  QGEN INVESTOR REMINDER: Hagens Berman Reminds Investors in Qiagen (QGEN) of Firms Ongoing Investigation Involving Possible Securities Law Violations ACCESSWIRE
Oct-10-19 01:41PM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:19PM  QIAGEN Down on Dim Q3 Prelim Sales, Startling CEO Departure Zacks
08:42AM  QIAGEN Inks Deal With Illumina to Deliver NGS-Based IVD Kits Zacks
Oct-09-19 08:03PM  QGEN SHAREHOLDER REMINDER: Hagens Berman Notifies Investors in Qiagen (QGEN) of Firms Ongoing Investigation Involving Possible Securities Law Violations GlobeNewswire
12:43PM  A Look At Benzinga Pro's Most-Searched Tickers For October 9, 2019 Benzinga
12:12PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Qiagen N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:11AM  QGEN LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of Qiagen N.V. PR Newswire
08:37AM  Illumina (ILMN) Inks Deal to Commercialize NGS-Based IVD Kits Zacks
Oct-08-19 10:01PM  QGEN SHAREHOLDER ALERT: Hagens Berman Notifies Investors in Qiagen (QGEN) of an Investigation Involving Possible Securities Law Violations PR Newswire -20.74%
08:11PM  Bragar Eagel & Squire, P.C. is Investigating Qiagen, Inc. (NYSE: QGEN) on Behalf of Qiagen Stockholders and Encourages Qiagen Investors to Contact the Firm Business Wire
07:28PM  EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against QIAGEN N.V. QGEN Business Wire
06:05PM  QGEN LOSSES ALERT: Bernstein Liebhard LLP Announces An Investigation of Qiagen N.V. ACCESSWIRE
04:13PM  This DNA Testing Stock Was Hammered On Its Lame Third-Quarter View Investor's Business Daily
03:33PM  SHAREHOLDER ALERT: Gardy & Notis, LLP Investigation Of Shareholder Claims Against Qiagen (NYSE: QGEN) PR Newswire
03:16PM  Qiagens Results Are Hitting Health-Care Stocks. Heres What to Do Next. Barrons.com
09:45AM  Qiagen Shares Tumble Following Q3 Sales Warning, Sudden CEO Departure Benzinga
08:56AM  Qiagen Stock Plunges as CEO Departs, Sales Fall Short Barrons.com
07:11AM  The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration Benzinga
05:34AM  [video]Qiagen Tumbles on Sales Warning, CEO Departure TheStreet.com
03:31AM  Qiagen shares stumble on sales warning, CEO departure MarketWatch
Oct-07-19 04:07PM  QIAGEN Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation Business Wire
04:07PM  QIAGEN Announces CEO Leadership Transition Business Wire
04:07PM  QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests Business Wire
04:05PM  Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests Business Wire
Sep-30-19 04:08PM  QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays and Analyses for Life Science Research Business Wire
03:34PM  We Think QIAGEN (NYSE:QGEN) Is Taking Some Risk With Its Debt Simply Wall St.
Sep-20-19 11:56AM  QIAGEN (QGEN) Hurt by Low QuantiFERON-TB Sales & FX Headwind Zacks
Sep-11-19 02:48PM  Does QIAGEN (NYSE:QGEN) Deserve A Spot On Your Watchlist? Simply Wall St.
Sep-10-19 01:30AM  QIAGEN Announces Change in Global Sales Structure Business Wire
Aug-26-19 09:52AM  Estimating The Fair Value Of QIAGEN N.V. (NYSE:QGEN) Simply Wall St.
Aug-23-19 09:31AM  Qiagen (QGEN) Down 8.7% Since Last Earnings Report: Can It Rebound? Zacks
Aug-16-19 09:51AM  QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results Zacks
Aug-14-19 04:05PM  QIAGENs New QIAstat-Dx Gastrointestinal Panel Demonstrates Excellent Performance in Multicenter Clinical Study in Europe Business Wire
Aug-09-19 11:16AM  Inovio (INO) Q2 Earnings & Revenues Fall Shy of Estimates Zacks
08:18AM  QIAGEN N.V. (NYSE:QGEN) Insiders Have Been Selling Simply Wall St.
Aug-05-19 05:36AM  Edited Transcript of QGEN earnings conference call or presentation 31-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-02-19 03:07PM  Qiagen Slips Up but Is Far From Broken Motley Fool
Aug-01-19 02:38PM  Bank of Italy Buys Qiagen NV, Sells Ferrari NV GuruFocus.com
Jul-31-19 10:23PM  Qiagen NV (QGEN) Q2 2019 Earnings Call Transcript Motley Fool
08:51AM  QIAGEN (QGEN) Misses Q2 Earnings Estimates, Lowers View Zacks
Jul-30-19 04:05PM  QIAGEN reports full results for second quarter and first half of 2019 Business Wire
Jul-24-19 08:55PM  Qiagen (QGEN) Q2 Earnings and Revenues Miss Estimates Zacks
04:09PM  QIAGEN Reports Results for Second Quarter of 2019; Updates Full-Year 2019 Outlook Due to Decision to Restructure China NGS Partnership Business Wire
Jul-23-19 10:32AM  Qiagen (QGEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, target enrichment, and library preparation for sequencing applications; and assay technology solutions. It also provides Ingenuity Variant Analysis, an application for analysis and interpretation of human sequencing data generated with next-generation sequencing (NGS) technologies; QIAGEN Clinical Insight, an evidence-based variant classification; CLC Genomics Workbench for the analysis and visualization of data from various NGS platforms; and GeneGlobe, a Web-based portal that enables researchers to search and order bioinformatics solutions and linking biological interpretation from pre-designed and custom PCR assay kits, NGS assay panels, and other products. In addition, the company offers instrumentation systems for laboratories. Its automation platforms include QIAsymphony, a modular system; QIAsymphony SP for sample preparation; QIAsymphony AS for assay setup; Rotor-Gene Q, a rotary real-time PCR cycler system; QIAstat-Dx for molecular analysis of common syndromes; GeneReader NGS System, a sample to insight NGS solution for laboratories; NeuMoDx 288 and NeuMoDx 96 for automation of higher-throughput PCR testing in clinical laboratories; and QIAcube and QIAcube connect workstations, which provides versatile solutions for automated sample processing; It serves molecular diagnostics, applied testing, pharma, and academia customers. QIAGEN N.V. has collaboration agreements with Ares Genetics and Laboratory Corporation of America Holdings; Inovio Pharmaceuticals Inc.; NanoCellect Biomedical, Inc.; and DiaSorin. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.